Skip to content
value.today

Satellite Biosciences, Inc.

Total raised
$101 M
2 rounds on record
Latest round
$82 M
Feb 2022
First round on record
Nov 2020
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Satellite Biosciences, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2022$82 MNo. 2$50 to $250 million

Satellite Biosciences, Inc.: Raise no. 2, Feb 2022

Investors in this round

10 investors had bought by the notice of Mar 11, 2022: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$82 M of $100 M offered; $18 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Lennon · Executive Officer, Director
  • Diane Marcou · Executive Officer
  • Laura Lande-Diner · Executive Officer
  • Christopher Chen · Director, Promoter
  • Eileen McGuire · Director
  • Ling Wong · Director
  • William Young · Director
  • Yair Schindel · Director · Yair Schindel was elected as a Director upon the Date of First Sale.
  • Sangeeta Bhatia · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by David Lennon, President. Newest notice filed Mar 11, 2022. Read the notice at the SEC.

equitySEC
Nov 2020$19 MNo. 1$10 to $50 million

Satellite Biosciences, Inc.: Raise no. 1, Nov 2020

Investors in this round

7 investors had bought by the notice of Nov 17, 2020: 7 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$19 M of $19 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Thomas Lowery · Executive Officer
  • Christopher Chen · Director, Promoter
  • Ellie McGuire · Director · Ellie McGuire was elected as a Director upon the Date of First Sale.
  • Ling Wong · Director · Ling Wong was elected as a Director upon the Date of First Sale.
  • Sujata Bhatia · Director · Sujata Bhatia served as a Director on the date the Board of Directors approved the offering. She resigned as a Director
  • William Young · Director · William Young was elected as a Director upon the Date of First Sale.
  • Sangeeta Bhatia · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Thomas Lowery, President. Newest notice filed Nov 17, 2020. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Satellite Biosciences, Inc. chose not to state its revenue in its newest notice of a funding round (Mar 2022).

    SEC Form D · Mar 2022

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Mar 2022

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Satellite Biosciences, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Satellite Biosciences, Inc.
NameRoleNamed in
David LennonExecutive officerMar 2022
Diane MarcouExecutive officerMar 2022
Laura Lande-DinerExecutive officerMar 2022
Thomas LoweryExecutive officerNov 2020
Christopher ChenDirectorMar 2022
David LennonDirectorMar 2022
Eileen McGuireDirectorMar 2022
Ling WongDirectorMar 2022
William YoungDirectorMar 2022
Yair SchindelYair Schindel was elected as a Director upon the Date of First Sale.Mar 2022
Ellie McGuireEllie McGuire was elected as a Director upon the Date of First Sale.Nov 2020
Sujata BhatiaSujata Bhatia served as a Director on the date the Board of Directors approved the offering. She resigned as a DirectorNov 2020
Christopher ChenPromoterMar 2022
Sangeeta BhatiaPromoterMar 2022